238.Craig H., Sharib J.R., Ridberg R., Caldwell J., Shah-Patel D., Warner K., Brown M., Chao C., Nau C., Schwartz P., et al
FDA Updates Ozempic Label with Potential Blocked Intestines Side Effect, Also Reported with Wegovy and Mounjaro
And if youre interested in a GLP-1 medication like Wegovy for weight loss, the fact that its an injectable might be a deal-breaker
A separate Returns page mentions 12-hour cancellation as an eligible reason
Whats more, they replicated the same analyses in a separate cohort of patients with type 2 diabetes mellitus by comparing semaglutide with non-GLP1R agonist anti-diabetes medications
However, GLP-1 receptor agonists had no significant effects on the occurrence of thyroid cancer (RR 1.30, 95% CI 0.86-1.97), hyperthyroidism (RR 1.19, 95% CI 0.61-2.35), hypothyroidism (RR 1.22, 95% CI 0.80-1.87), thyroiditis (RR 1.83, 95% CI 0.51-6.57), thyroid mass (RR 1.17, 95% CI 0.43-3.20), and goiter (RR 1.17, 95% CI 0.74-1.86)